Role of drug-coated balloons in small-vessel coronary artery disease

Michael Megaly, Marwan Saad, Emmanouil S Brilakis

Research output: Contribution to journalArticle

Abstract

Percutaneous coronary intervention of small-vessel coronary artery disease (SVD) remains challenging due to difficulties with device delivery and high restenosis rate, even with the use of newer-generation drug-eluting stents. Drug-coated balloons represent an attractive emerging percutaneous coronary intervention option in patients with SVD. Potential advantages of drug-coated balloons in SVD include enhanced deliverability because of their small profile, avoidance of foreign-body implantation, and shorter duration of dual antiplatelet therapy.

Original languageEnglish (US)
Pages (from-to)16-20
Number of pages5
JournalUS Cardiology Review
Volume13
Issue number1
DOIs
StatePublished - Jan 1 2019
Externally publishedYes

Fingerprint

Percutaneous Coronary Intervention
Coronary Artery Disease
Drug-Eluting Stents
Foreign Bodies
Pharmaceutical Preparations
Equipment and Supplies
Therapeutics

Keywords

  • Coronary artery disease
  • Drug-coated balloons
  • Drug-eluting stents
  • Small-vessel disease

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Role of drug-coated balloons in small-vessel coronary artery disease. / Megaly, Michael; Saad, Marwan; Brilakis, Emmanouil S.

In: US Cardiology Review, Vol. 13, No. 1, 01.01.2019, p. 16-20.

Research output: Contribution to journalArticle

Megaly, Michael ; Saad, Marwan ; Brilakis, Emmanouil S. / Role of drug-coated balloons in small-vessel coronary artery disease. In: US Cardiology Review. 2019 ; Vol. 13, No. 1. pp. 16-20.
@article{d969fafe824d4decbb6b7dc68ba88fa2,
title = "Role of drug-coated balloons in small-vessel coronary artery disease",
abstract = "Percutaneous coronary intervention of small-vessel coronary artery disease (SVD) remains challenging due to difficulties with device delivery and high restenosis rate, even with the use of newer-generation drug-eluting stents. Drug-coated balloons represent an attractive emerging percutaneous coronary intervention option in patients with SVD. Potential advantages of drug-coated balloons in SVD include enhanced deliverability because of their small profile, avoidance of foreign-body implantation, and shorter duration of dual antiplatelet therapy.",
keywords = "Coronary artery disease, Drug-coated balloons, Drug-eluting stents, Small-vessel disease",
author = "Michael Megaly and Marwan Saad and Brilakis, {Emmanouil S}",
year = "2019",
month = "1",
day = "1",
doi = "10.14520/usc.2019.4.1",
language = "English (US)",
volume = "13",
pages = "16--20",
journal = "US Cardiology",
issn = "1758-3896",
publisher = "Radcliffe Publishing Ltd.",
number = "1",

}

TY - JOUR

T1 - Role of drug-coated balloons in small-vessel coronary artery disease

AU - Megaly, Michael

AU - Saad, Marwan

AU - Brilakis, Emmanouil S

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Percutaneous coronary intervention of small-vessel coronary artery disease (SVD) remains challenging due to difficulties with device delivery and high restenosis rate, even with the use of newer-generation drug-eluting stents. Drug-coated balloons represent an attractive emerging percutaneous coronary intervention option in patients with SVD. Potential advantages of drug-coated balloons in SVD include enhanced deliverability because of their small profile, avoidance of foreign-body implantation, and shorter duration of dual antiplatelet therapy.

AB - Percutaneous coronary intervention of small-vessel coronary artery disease (SVD) remains challenging due to difficulties with device delivery and high restenosis rate, even with the use of newer-generation drug-eluting stents. Drug-coated balloons represent an attractive emerging percutaneous coronary intervention option in patients with SVD. Potential advantages of drug-coated balloons in SVD include enhanced deliverability because of their small profile, avoidance of foreign-body implantation, and shorter duration of dual antiplatelet therapy.

KW - Coronary artery disease

KW - Drug-coated balloons

KW - Drug-eluting stents

KW - Small-vessel disease

UR - http://www.scopus.com/inward/record.url?scp=85063602907&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85063602907&partnerID=8YFLogxK

U2 - 10.14520/usc.2019.4.1

DO - 10.14520/usc.2019.4.1

M3 - Article

AN - SCOPUS:85063602907

VL - 13

SP - 16

EP - 20

JO - US Cardiology

JF - US Cardiology

SN - 1758-3896

IS - 1

ER -